ArticleScience translational medicine2025

An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer.

Meriem Bahri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.